Connor, Clark & Lunn Investment Management (CC&L)
OREX

Connor, Clark & Lunn Investment Management (CC&L)’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,870
Closed -$32K – 981
2015
Q4 		$32K Buy
+1,870
New +$32K ﹤0.01% 798